References
- 1. Aranow C. Vitamin D and the Immune System. J Investig Med. 2011 Aug;59(6):881–6. DOI: 10.231/JIM.0b013e31821b8755
- 2. Legeai C, Vigouroux C, Souberbielle J-C, Bouchaud O, Boufassa F, Bastard J-P, et al. Associations between 25-Hydroxyvitamin D and Immunologic, Metabolic, Inflammatory Markers in Treatment-Naive HIV-Infected Persons: The ANRS CO9 «COPANA» Cohort Study. PLoS ONE. 2013 Sep 18;8(9):e74868. DOI: 10.1371/journal.pone.0074868
- 3. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev. 2006 May;64(5 Pt 1):226–33. DOI: 10.1111/j.1753-4887.2006.tb00205.x
- 4. Wang T-T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. J Immunol. 2004 Sep 1;173(5):2909–12. DOI: 10.4049/jimmunol.173.5.2909
- 5. Yuk J-M, Shin D-M, Lee H-M, Yang C-S, Jin HS, Kim K-K, et al. Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin. Cell Host Microbe. 2009 Sep 17;6(3):231–43. DOI: 10.1016/j. chom.2009.08.004
- 6. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol. 2004 Feb 27;215(1-2):31–8. DOI: 10.1016/j.mce.2003.11.017
- 7. Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D–dependent mechanism. J Clin Invest. 2007 Mar 1;117(3):803–11. DOI: 10.1172/JCI30142
- 8. Adorini L. Control of Adaptive Immunity by Vitamin D Receptor Agonists. In: Feldman D, J. Wesley P, Adams JS, editors. Vitamin D, Academic Press; 2011. p.1789–809. DOI: 10.1016/b978-0-12-381978-9.10092-7
- 9. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol Baltim Md 1950. 2007 Aug 1;179(3):1634–47.
- 10. Mithal A, Wahl DA, Bonjour J-P, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009 Nov;20(11):1807–20. DOI: 10.1007/s00198-009-1030-y DOI: 10.1007/s00198-009-0954-6
- 11. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDs. 2010 Apr;24(4):223–7. DOI: 10.1089/apc.2009.0241
- 12. Mueller NJ, Fux CA, Ledergerber B, Elzi L, Schmid P, Dang T, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS. 2010 May 15;24(8):1127–34. DOI: 10.1097/QAD.0b013e328337b161
- 13. Bang UC, Shakar SA, Hitz MF, Jespersen MS, Andersen O, Nielsen SD, et al. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study. Scand J Infect Dis. 2010 Jan 19;42(4):306–10. DOI: 10.3109/00365540903463981
- 14. Holick MF, Binkley NC, Bishoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Jul; 96(7):1911-30. DOI: 10.1210/jc.2011-0385
- 15. European AIDS Clinical Society Guidelines 7.02.2014: http://www.eacsociety.org/Portals/0/140601_EACS%20EN7.02.pdf
- 16. Ozkan B, Hatun S, Bereket A. Vitamin D intoxication. Turk J Pediatr. 2012 Apr; 54(2):93–8.
- 17. Welz T, Childs K, Ibrahim F, Poulton M, Taylor CB, Moniz CF, et al. Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS. 2010 Jul; 24(12):1923–8. DOI: 10.1097/QAD.0b013e32833c3281
- 18. Whiting SJ, Calvo MS. Nutrition and Lifestyle Effects on Vitamin D Status. In: Feldman D, J. Wesley P, Adams JS, editors. Vitamin D. Academic Press; 2011. p.979–1007. DOI: 10.1016/b978-0-12-381978-9.10054-x
- 19. Han Y-P, Kong M, Zheng S, Ren Y, Zhu L, Shi H, et al. Vitamin D in liver diseases: From mechanisms to clinical trials. J Gastroenterol Hepatol. 2013 Aug 1;28:49–55. DOI: 10.1111/jgh.12016
- 20. Hollis BW. Detection of Vitamin D and its Major Metabolites. In: Feldman D, J. Wesley P, Adams JS, editors. Vitamin D. Academic Press; 2011. p.823–44. DOI: 10.1016/b978-0-12-381978-9.10047-2
- 21. Binkley N, Ramamurthy R, Krueger D. Low Vitamin D Status: Definition, Prevalence, Consequences, and Correction. Endocrinol Metab Clin North Am. 2010 Jun; 39(2):287–301. DOI: 10.1016/j.ecl.2010.02.008
- 22. Viljoen A, Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. J Clin Lab Anal. 2011;25(2):130–3. DOI: 10.1002/jcla.20446
- 23. Brescia V. Biological Variability of Serum 25-Hydroxyvitamin D and Other Biomarkers in Healthy Subjects. LabMedicine. 2013;44(1):20-24. DOI: 10.1309/lmf62nsleryc8pad
- 24. Adeyemi OM, Agniel D, French AL, Tien PC, Weber K, Glesby MJ, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):197–204. DOI: 10.1097/QAI.0b013e31821ae418
- 25. Bearden A, Abad C, Gangnon R, Sosman JM, Binkley N, Safdar N. Cross sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab. April 2013, 98(4):1726-1733. DOI: 10.1210/jc.2012-4031
- 26. Mehta S, Giovannucci E, Mugusi FM, Spiegelman D, Aboud S, Hertzmark E, et al. Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality. PLoS ONE. 2010 Jan 19;5(1):e8770. DOI: 10.1371/journal.pone.0008770
- 27. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect Dis. 2013 Jan 19;13(1):22. DOI: 10.1186/1471-2334-13-22